Baby’s 1st Christmas Event

Translate to Spanish or other 102 languages!

Courtesy Image

Mega Doctor News

- Advertisement -

EDINBURG – Precinct 4, in partnership with Texas A&M University Colonias Program and Driscoll Health Plan will be hosting “Baby’s 1st Christmas” on Friday, December 10, 2021 from 9:00 am until 11:00 am at the Pct. 4 Endowment Center located at 107 N. Sunflower Road in Edinburg.

Courtesy Image

Expectant mothers or parents with children under the age of 8 months may attend the event. Please bring a sonogram or baby’s picture to make a special ornament. Face masks are highly recommended.

Health education sessions will be conducted on several topics that include infant immunizations, lactation techniques, and other health topics for infant care.  

- Advertisement -

“It brings me great joy to have so many great organizations come together at the Endowment Center to share a wealth of knowledge with first-time parents.  It takes a village to raise a child and we need to do our part in the county to help parents learn about health and safety for their children,” stated Precinct 4 Commissioner Ellie Torres. 

For more information, please contact the Hidalgo County Precinct 4 Endowment Center at (956) 289-7429. 

Hidalgo County Commissioner Ellie Torres, Precinct 4

Baby’s 1st Christmas Event

- Advertisement -

9:00 a.m. – 11:00 a.m., Friday, December 10, 2021

107 N. Sunflower Road, Edinburg, TX

For questions or concerns regarding this event please call 956-289-7429.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Texas Adds New Condition to Mandatory Newborn Screening Tests

The Texas Department of State Health Services added a new enzyme deficiency test on June 1, 2026, to its newborn screening panel, meaning that all Texas newborns are now tested for 60 rare, genetic conditions. Tests for hearing loss and critical congenital heart disease are additional point-of-service tests typically conducted by the birthing center. 

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.

STHS GME Consortium Encourages Community to “Walk with a Doc”, June 6th

Mega Doctor News In an era defined by high-intensity workouts, wearable fitness trackers and advanced training techniques, one of simplest...

STHS Children’s Marks 20th Anniversary with Gala Honoring Pediatric Providers Behind Its Success

For the past 20 years, South Texas Health System Children’s has stood as a place where compassionate care and clinical excellence come together to create hope for children and their families.
- Advertisement -